F W Reimherr

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures
    Dawson W Hedges
    Department of Psychology, Brigham Young University, Provo, Utah 84602, USA
    J Clin Psychiatry 64:1449-54. 2003
  2. ncbi request reprint Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis
    Reid J Robison
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    J Clin Psychiatry 69:213-21. 2008
  3. ncbi request reprint OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study
    Barrie K Marchant
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT, USA
    Ann Clin Psychiatry 22:196-204. 2010
  4. ncbi request reprint Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression
    F W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City 83132, USA
    J Clin Psychiatry 62:16-23. 2001
  5. doi request reprint A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole
    Frederick W Reimherr
    University of Utah School of Medicine, Salt Lake City, UT 84123, USA
    J Clin Psychopharmacol 30:300-5. 2010
  6. ncbi request reprint Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:103-12. 2010
  7. ncbi request reprint Emotional dysregulation in adult ADHD and response to atomoxetine
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Biol Psychiatry 58:125-31. 2005
  8. doi request reprint Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine
    Frederick Reimherr
    Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Psychiatry Res 175:67-73. 2010
  9. ncbi request reprint Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD
    Reid J Robison
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:94-102. 2010
  10. ncbi request reprint Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate
    Erika D Williams
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:84-93. 2010

Detail Information

Publications21

  1. ncbi request reprint Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures
    Dawson W Hedges
    Department of Psychology, Brigham Young University, Provo, Utah 84602, USA
    J Clin Psychiatry 64:1449-54. 2003
    ..This article describes further analyses investigating topiramate's effect on psychological symptoms associated with disordered eating...
  2. ncbi request reprint Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis
    Reid J Robison
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    J Clin Psychiatry 69:213-21. 2008
    ....
  3. ncbi request reprint OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study
    Barrie K Marchant
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT, USA
    Ann Clin Psychiatry 22:196-204. 2010
    ..Important findings from the double-blind phase are reexamined for long-term significance...
  4. ncbi request reprint Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression
    F W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City 83132, USA
    J Clin Psychiatry 62:16-23. 2001
    ....
  5. doi request reprint A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole
    Frederick W Reimherr
    University of Utah School of Medicine, Salt Lake City, UT 84123, USA
    J Clin Psychopharmacol 30:300-5. 2010
    ..These analyses aimed to examine the pattern of improvement in depression symptoms with adjunctive aripiprazole...
  6. ncbi request reprint Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:103-12. 2010
    ..This study explored the relationship between the dimensions of adult attention-deficit/hyperactivity disorder (ADHD), personality disorder (PD), and adverse social adjustment...
  7. ncbi request reprint Emotional dysregulation in adult ADHD and response to atomoxetine
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Biol Psychiatry 58:125-31. 2005
    ....
  8. doi request reprint Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine
    Frederick Reimherr
    Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Psychiatry Res 175:67-73. 2010
    ..Although this study is speculative, it represents a pharmacologically and genotypically well-defined patient population...
  9. ncbi request reprint Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD
    Reid J Robison
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:94-102. 2010
    ..This study explored the relationship between personality disorder (PD) and treatment response in a randomized, double-blind, clinical trial of osmotic release oral system (OROS) methylphenidate (MPH)...
  10. ncbi request reprint Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate
    Erika D Williams
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:84-93. 2010
    ..Comorbidity of personality disorder (PD) and attention-deficit/hyperactivity disorder (ADHD) has been suggested in several reports. However, assessment of PD is problematic, and studies have over-relied on baseline evaluations...
  11. ncbi request reprint Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression
    P J McGrath
    Department of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, USA
    J Clin Psychiatry 61:518-24. 2000
    ..The goal was to examine predictors of relapse during continuation/maintenance treatment of major depression that had remitted following 12 to 14 weeks of fluoxetine therapy...
  12. ncbi request reprint Comorbidity and diagnosis of ADHD
    Frederick W Reimherr
    Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, Utah, USA
    CNS Spectr 11:7-9. 2006
  13. ncbi request reprint A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    J Clin Psychiatry 68:93-101. 2007
    ..Osmotic release oral system (OROS) methylpheni-date is a long-acting stimulant demonstrated to be effective in the treatment of children and adolescents with ADHD...
  14. doi request reprint Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms
    Robert E Strong
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Depress Anxiety 26:273-8. 2009
    ..To more stringently test the importance of these wavelengths, bright red-light was used for the placebo (control) condition...
  15. ncbi request reprint Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
    J Clin Psychopharmacol 26:648-52. 2006
    ..Despite the existence of research demonstrating the effects of ADHD on certain aspects of life, the clinical trials of treatments for this disorder have focused primarily on efficacy and safety...
  16. doi request reprint Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder
    Jay D Amsterdam
    Depression Research Unit, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 3309, USA
    Neuropsychobiology 59:227-33. 2009
    ..The aim of this post hoc analysis was to examine whether tachyphylaxis occurs after repeated courses of antidepressant drug therapy...
  17. ncbi request reprint The reliability and validity of self- and investigator ratings of ADHD in adults
    Lenard A Adler
    New York University School of Medicine, New York, NY 10016, USA
    J Atten Disord 11:711-9. 2008
    ....
  18. ncbi request reprint Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
    David Michelson
    Lilly Research Laboratories, Indianapolis, Indiana 46285, USA
    Biol Psychiatry 53:112-20. 2003
    ..To assess the efficacy of atomoxetine, a new and highly selective inhibitor of the norepinephrine transporter, we conducted two large, multicenter treatment trials...
  19. ncbi request reprint Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study
    David Michelson
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, Ind, USA
    J Clin Psychiatry 68:582-7. 2007
    ..Addition of a noradrenergic intervention in patients poorly or partially responsive to SSRIs may improve outcomes, but few well-controlled studies testing this hypothesis have been reported...
  20. ncbi request reprint Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures
    Scott P Hoopes
    Mountain West Clinical Trials, Boise, Idaho 83704, USA
    J Clin Psychiatry 64:1335-41. 2003
    ..This randomized, double-blind, placebo-controlled trial was designed to assess the efficacy and safety of topiramate in bulimia nervosa...
  21. ncbi request reprint Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
    David J Brunswick
    The Depression Research Unit, University of Pennsylvania Medical Center, University Science Center, 8th Floor, 3600 Market Street, Philadelphia, PA 19104, USA
    J Affect Disord 68:243-9. 2002
    ..The purpose of this study was to investigate the relationship between steady-state plasma drug concentrations and outcome during relapse-prevention therapy with fluoxetine...